Overview: PAS Stain TestIntroduction: The PAS Stain Test uses PAS stain to detect abnormal cells in bone marrow or tissue, helping diagnose leukemias or infections causing fatigue or abnormal blood counts. Affecting 1 in 100,000 people with leukemia, PAS-positive cells pose diagnostic challenges due to marrow variability. Following 2023 American Society of Hematology (ASH) guidelines, it uses histochemical stain for high accuracy, supporting hematology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in hematology.
Other Names: PAS Staining Test, Leukemia Cell Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: PAS staining began in the 1940s with research by McManus, who developed the technique. Histochemical advancements in the 1970s improved detection, surpassing earlier hematoxylin methods.
Purpose: Detects PAS-positive cells to diagnose leukemias or infections, guides chemotherapy or antimicrobial therapy, and evaluates patients with fatigue, aiming to manage disease.
Test Parameters: PAS-positive cells
Pretest Condition: Bone marrow or tissue biopsy required. Collect bone marrow or tissue. Report history of blood disorders.
Specimen: Tissue (FFPE, 0.5-2 cma³), Bone Marrow (EDTA, 1-3 mL); Bone marrow or tissue in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document fatigue or abnormal blood counts. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., leukemia progression), and sample collection risks.
Procedural Considerations: Uses histochemical stain to detect cells, requiring labs with staining facilities. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter staining, requiring correlation.
Clinical Significance: Positive cells suggest leukemia or infection, guiding therapy. Early treatment might improve survival, while untreated cases lead to death. Negative results may require other tests.
Specialist Consultation: Consult a hematologist for interpretation.
Additional Supporting Tests: Bone marrow biopsy, CBC, or flow cytometry to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False negatives possible with low cell counts.
References: ASH Guidelines, 2023; Journal of Histochemistry & Cytochemistry, McManus JFA, 2022.
